HOME >> MEDICINE >> NEWS
Zengen reports positive phase I/II trial results of its peptide molecule for vaginal yeast infection

(May 25, 2004) Zengen Inc. announced today positive phase I/II results for its proprietary molecule CZEN-002 for the treatment of vulvovaginal candidiasis (VVC), commonly known as vaginal yeast infection. The open label, non-randomized study was designed to evaluate the safety, tolerability and pharmacokinetics of CZEN-002 in patients with VVC.

The majority of subjects in the study reported evidence of efficacy as determined by potassium hydroxide (KOH) tests and mycological cultures - 88.2 percent and 87.5 percent, respectively. A total of 20 female patients with VVC were enrolled and treated in the trial, and 17 completed the study. KOH testing and mycological cultures indicated that CZEN-002 is active and that five days of treatment provided positive evidence of anti-infective efficacy. CZEN-002 appeared safe and well-tolerated with no severe adverse reactions. In 100 percent of the plasma samples evaluated, concentrations of CZEN 002 were either not detected or were below the limit of quantitation.

"This trial clearly established the efficacy of CZEN-002," said William Smith, M.D., F.A.C.C., lead study investigator and associate professor, clinical medicine, at Tulane University School of Medicine and Louisiana State University Medical Center. "The encouraging results provide hope that this compound may become a new treatment option for the millions of women diagnosed each year with VVC."

The primary objective of the study was to evaluate the safety and tolerability of vaginally administered CZEN-002. A secondary objective was to assess the systemic absorption of CZEN-002 as determined by the plasma concentrations of the molecule through 21 days following dosing. The CZEN 002 was delivered to the 20 patients in a vaginal gel specifically designed for the purpose of the study.

"This clinical trial marks a major milestone for Zengen," said James M. Lipton, Ph.D., chief scientific officer of Zengen. "Our peptide appears to
'"/>

Contact: Cattaliya Snider
sniderc@ruderfinn.com
310-479-9929
Zengen
25-May-2004


Page: 1 2 3

Related medicine news :

1. Zengens new study reviews novel approach to control inflammation using melanocortin receptors
2. Lead in the environment causes violent crime, reports University of Pittsburgh researcher at AAAS
3. Study reports women dont experience undue pain, anxiety during mammography screening
4. Risks from labor after prior cesarean delivery low, study reports
5. Federal forum reports Americans aging well, but gaps remain
6. Early reports of thrombosis after insertion of drug-eluting stents
7. Study reports genetic susceptibility to alcoholism in NMDA receptor
8. Parents can provide accurate reports of their childrens ADHD symptoms
9. UCI Tobacco research center reports why teens are most vulnerable to smoking addiction
10. MIT reports new insights in visual recognition
11. Study reports improved method to identify fetal DNA in maternal blood samples

Post Your Comments:
(Date:4/21/2015)... (PRWEB) April 21, 2015 Dr. Zain Kadri, ... released an interesting infographic that takes a close look at ... The new infographic, which appears on both Dr. Kadri’s website ... of Plastic Surgery in the Age of the Selfie.” According ... Beverly Hills to a variety of A-list patients, the ...
(Date:4/21/2015)... Spring and summer are popular seasons to ... for the holidays or simply taking vacations. Deciding what ... can be a difficult choice. Pet-friendly accommodations are gaining ... becoming a more common option. Royal Flush Havanese ... pet-friendly accommodations a positive experience. , 1.) Firstly, it ...
(Date:4/20/2015)... EDINBURGH, Scotland (PRWEB) April 21, 2015 When ... fatigue syndrome (CFS), she felt as if nothing could ... Health Service estimates that 250,000 U.K. citizens are currently living ... to take action. Her new book, “ Living a Life ... Mind, Body, Home, and Environment. Create a Happier, Healthier Life ...
(Date:4/20/2015)... 21, 2015 Is it possible to create ... relevant to the local needs of the providers, payers and ... was embraced over the past year by the Hutchinson Institute ... Cancer Research Center in Seattle, Washington. , In a new ... The American Journal of Managed Care, HICOR Director Scott ...
(Date:4/20/2015)... CT (PRWEB) April 20, 2015 Global ... Lyme” Gala, held last Saturday at the Hyatt Regency ... a cure for Lyme and other debilitating tick-borne diseases. ... volunteers, donors, friends and families who made this year’s ... “Their dedication to advancing research and education initiatives to ...
Breaking Medicine News(10 mins):Health News:Beverly Hills Plastic Surgery Expert Dr. Zain Kadri Releases Thought-Provoking New Infographic 2Health News:Royal Flush Havanese Announces 5 Tips for a Successful Stay in Pet-Friendly Accommodations 2Health News:Royal Flush Havanese Announces 5 Tips for a Successful Stay in Pet-Friendly Accommodations 3Health News:Royal Flush Havanese Announces 5 Tips for a Successful Stay in Pet-Friendly Accommodations 4Health News:New book by Faith Canter offers guide to banishing toxins 2Health News:Creating Value Metrics in Cancer Care From the Bottom Up 2Health News:Creating Value Metrics in Cancer Care From the Bottom Up 3Health News:Global Lyme Alliance's “Time for Lyme” Gala Raises Over $850,000 for Tick-Borne Disease Research 2Health News:Global Lyme Alliance's “Time for Lyme” Gala Raises Over $850,000 for Tick-Borne Disease Research 3
(Date:4/20/2015)... --  Precision Image Analysis (PIA) is sponsoring a ... cardiovascular imaging and post-processing. Scott D. Flamm , ... Cardiovascular Magnetic Resonance (SCMR) will be presenting this ... by providing broader access to Cardiac MRI (CMR). ... understand appropriate use of CMR, the strengths of CMR ...
(Date:4/20/2015)... FRANCISCO , April 20, 2015  SillaJen, ... the development of oncolytic immunotherapy products for cancer, ... research at the Annual Meeting of the American ... of a murine adapted version of its lead ... Pexa-Vec is an oncolytic immunotherapy designed to ...
(Date:4/20/2015)... 2015 The global orthopedic braces ... concerned global with analysis and forecast of revenue. This ... estimated to reach $4,918.7 million by 2019, at a ... Browse through the TOC of global orthopedic braces & ... industry trends and segments, with help of various tables ...
Breaking Medicine Technology:Educational Webinar Teaches Improved Patient Management Through Broader Access to Cardiac MRI 2SillaJen Presents Data Demonstrating Pexa-Vec Synergy with Angiogenesis Inhibitors: A Collaboration with University of California, San Francisco 2SillaJen Presents Data Demonstrating Pexa-Vec Synergy with Angiogenesis Inhibitors: A Collaboration with University of California, San Francisco 3Global Orthopedic Braces & Support System Market is Expected to Reach $4,918.7 Million by 2019, at a CAGR of 4.4% from 2014 to 2019 2Global Orthopedic Braces & Support System Market is Expected to Reach $4,918.7 Million by 2019, at a CAGR of 4.4% from 2014 to 2019 3
Cached News: